Now that the patent for the brand-name version has expired, four different generic Bentyl (dicyclomine) products are currently available. The generic medication comes in capsule, tablet, syrup, and injectable form, and is manufactured by several drug companies. The U.S. Food and Drug Administration considers all generic Bentyl products to be equivalent to the brand-name version.
Bentyl® (dicyclomine hydrochloride) is a prescription drug that belongs to a group of medications known as anticholinergics. It is approved for treating irritable bowel syndrome (IBS).
Brand-name Bentyl is made by Pantheon Pharmaceuticals, Inc. and Akorn, Inc., and is marketed by Axcan Scandipharm, Inc. However, the patent has expired and generic Bentyl is now available.
Generic Bentyl is available in the following strengths and forms:
- Dicyclomine 10 mg capsules
- Dicyclomine 20 mg tablets
- Dicyclomine 10 mg/5 mL syrup (with 10 mg per teaspoonful)
- Dicyclomine 20 mg/2 mL injection.
Generic Bentyl is made by several different companies, such as:
- Watson Laboratories
- Mylan Pharmaceuticals
- Major Pharmaceuticals.
All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one. An "AB," "AA," or "AP" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic dicyclomine versions currently available have one of these ratings, meaning they should be equivalent to Bentyl.
However, generic medications are allowed to have different inactive ingredients than the brand-name medications. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.